Whitepaper
Replacing clinical trials and registries
Generating high-quality clinical evidence has never been more urgent. As healthcare costs rise and patient needs grow, the industry demands faster, more affordable solutions to assess the safety and effectiveness of drugs, devices, and treatments. Traditional clinical trials are costly, time-consuming, and often limited in generalizability. Truveta Data offers a scalable, scientifically rigorous alternative, enabling researchers to replace certain types of clinical trials with real-time insights from over 120 million patients.
This whitepaper provides insight into:
- The limitations of clinical trials and the benefits of real-world data for generating faster, more contemporary clinical insights
- Why Truveta Data offers a superior alternative to registries, standalone claims datasets, and other real-world datasets
- How Truveta Data compares to randomized controlled trial and registry results, using published examples
- How Truveta Data can be used for postmarket studies and synthetic control arms
